# ENDOCHAIN Implementation & Clinical Operations Manual

**Creator:** Ariel Viduya Manosca | **Author:** IAMVC holdings LLC

**Version:** 2.0  
**Date:** November 2025  
**Audience:** Clinical Implementers, IT Administrators, Healthcare Providers

---

## 1. Pre-Implementation Checklist

### 1.1 Institutional Requirements

- [ ] **IRB/Ethics Approval:** Obtain approval for clinical validation or patient assessment
- [ ] **HIPAA/PRIVACY COMPLIANCE:** Business Associate Agreements (BAAs) with ENDOCHAIN
- [ ] **CLIA CERTIFICATION:** Clinical laboratory standards if on-site analysis used
- [ ] **EHR INTEGRATION:** API credentials from hospital information system
- [ ] **NETWORK INFRASTRUCTURE:** Minimum 10 Mbps dedicated bandwidth; VPN access
- [ ] **STAFF TRAINING:** Identify 2â€“3 clinician champions; schedule 4-hour training
- [ ] **HARDWARE PROVISIONING:** 
  - [ ] Regenerative Spark Lattice (RSL) device + charging station
  - [ ] Ethernet connection or WiFi 6 for data transmission
  - [ ] DICOM PACS workstation integration (if imaging-based workflow)
- [ ] **BUDGET ALLOCATION:** Per-assessment licensing; platform integrations

---

## 2. Installation & System Setup

### 2.1 Cloud Deployment (AWS)

**Step 1: AWS Account Setup**
```bash
# Create IAM user with programmatic access
aws iam create-user --user-name endochain-deployer
aws iam attach-user-policy --user-name endochain-deployer \
  --policy-arn arn:aws:iam::aws:policy/PowerUserAccess

# Generate credentials
aws iam create-access-key --user-name endochain-deployer
# â†’ Save AWS_ACCESS_KEY_ID and AWS_SECRET_ACCESS_KEY securely
```

**Step 2: Deploy Infrastructure via Terraform**
```bash
cd endochain-deployment/terraform

# Initialize Terraform
terraform init

# Review planned infrastructure
terraform plan -var="environment=production" \
               -var="region=us-east-1" \
               -out=tfplan

# Apply deployment
terraform apply tfplan

# Outputs: RDS endpoint, ECS cluster name, API Gateway URL
terraform output
```

**Step 3: Initialize Database**
```bash
# Connect to RDS
psql -h <RDS_ENDPOINT> -U postgres -c "CREATE DATABASE endochain_prod;"

# Run migrations
python3 endochain/migrate.py --env production
```

**Step 4: Deploy Containerized Services**
```bash
# Push Docker images to ECR
aws ecr get-login-password --region us-east-1 | \
  docker login --username AWS --password-stdin <ECR_REGISTRY>

docker build -t endochain/vlg-engine:2.0 ./vlg_engine
docker tag endochain/vlg-engine:2.0 <ECR_REGISTRY>/vlg-engine:2.0
docker push <ECR_REGISTRY>/vlg-engine:2.0

# Deploy via ECS
aws ecs update-service --cluster endochain-prod \
  --service vlg-engine \
  --force-new-deployment
```

### 2.2 On-Premise Deployment (Docker Compose)

**System Requirements:**
- **OS:** Ubuntu 22.04 LTS or RHEL 8.x
- **CPU:** 8-core minimum; 16-core recommended
- **RAM:** 32 GB minimum
- **Storage:** 500 GB SSD for data; 1 TB for long-term backups
- **Network:** 10 Mbps minimum uplink; firewall rule for port 443

**Installation Script:**
```bash
#!/bin/bash
set -e

# Install dependencies
sudo apt-get update && sudo apt-get install -y \
    docker.io \
    docker-compose \
    postgresql-client \
    curl

# Add user to docker group
sudo usermod -aG docker $USER

# Clone ENDOCHAIN repository
git clone https://github.com/iamvc/endochain.git
cd endochain

# Create environment file
cat > .env << EOF
ENVIRONMENT=production
DB_PASSWORD=$(openssl rand -base64 32)
JWT_SECRET=$(openssl rand -base64 32)
GOOGLE_API_KEY=<INSERT_KEY>
AZURE_API_KEY=<INSERT_KEY>
TLS_CERT_PATH=/etc/endochain/certs/server.crt
TLS_KEY_PATH=/etc/endochain/certs/server.key
EOF

# Generate self-signed TLS certificates (or use CA-signed)
mkdir -p /etc/endochain/certs
openssl req -x509 -newkey rsa:4096 -keyout /etc/endochain/certs/server.key \
  -out /etc/endochain/certs/server.crt -days 365 -nodes

# Launch services
docker-compose -f docker-compose.prod.yml up -d

# Health check
sleep 10
curl -k https://localhost/health
echo "âœ“ ENDOCHAIN services running"
```

---

## 3. Clinical Workflow Integration

### 3.1 Patient Enrollment & Data Collection

**Workflow Step 1: Patient Registration**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ 1. Patient Scheduling Appointment    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Enroll in ENDOCHAIN study/clinical â”‚
â”‚ â€¢ Confirm diagnostic visit (+/- imaging)
â”‚ â€¢ Schedule 96-hour V-CAW window      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ 2. Pre-Assessment Questionnaire      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Via Azure Health Bot chatbot       â”‚
â”‚ â€¢ Symptom severity (visual analog)   â”‚
â”‚ â€¢ Menstrual history (LMP, cycle)     â”‚
â”‚ â€¢ Medical/surgical comorbidities     â”‚
â”‚ â€¢ Medications (esp. hormonal agents) â”‚
â”‚ â€¢ Estimated ovulation date           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ 3. Clinical Encounter                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Physical exam (abdominal, pelvic)  â”‚
â”‚ â€¢ Blood/saliva sampling (if consented)
â”‚ â€¢ Imaging (transvaginal ultrasound)  â”‚
â”‚ â€¢ RSL device electrode placement     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ 4. V-CAW Data Collection (96 hours)  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ RSL impedance sampling (hourly)    â”‚
â”‚ â€¢ Patient symptom logs (4 samples/day)
â”‚ â€¢ Cycle day confirmation (LH strips) â”‚
â”‚ â€¢ Lab biomarkers (if available)      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Data Entry Form (FHIR-Compliant):**

```html
<form id="endochain-intake">
  <fieldset>
    <legend>ENDOCHAIN Patient Assessment (v2.0)</legend>
    
    <!-- Demographics -->
    <label>Patient ID: <input type="text" name="patient_id" readonly></label>
    <label>Date of Birth: <input type="date" name="dob" required></label>
    <label>Gender: 
      <select name="gender">
        <option value="female">Female</option>
        <option value="other">Other</option>
      </select>
    </label>
    
    <!-- Cycle Information -->
    <label>Last Menstrual Period (LMP):
      <input type="date" name="lmp" required>
    </label>
    <label>Cycle Length (days):
      <input type="number" name="cycle_length" min="21" max="35">
    </label>
    <label>Estimated Ovulation Date:
      <input type="date" name="estimated_ovulation" required>
    </label>
    
    <!-- Symptom Assessment (Visual Analog Scale) -->
    <label>Pelvic Pain Severity (0â€“10):
      <input type="range" name="pain_severity" min="0" max="10">
      <span id="pain-value">0</span>/10
    </label>
    
    <label>Dysmenorrhea Severity (0â€“10):
      <input type="range" name="dysmenorrhea" min="0" max="10">
    </label>
    
    <label>Dyspareunia (Pain During Intercourse):
      <input type="checkbox" name="dyspareunia"> Yes
    </label>
    
    <!-- Imaging & Lab Data -->
    <label>Imaging Type:
      <select name="imaging_type">
        <option>None</option>
        <option>Transvaginal Ultrasound (DICOM)</option>
        <option>MRI Pelvis (DICOM)</option>
        <option>Other</option>
      </select>
    </label>
    
    <label>Upload DICOM File:
      <input type="file" name="dicom_file" accept=".dcm">
    </label>
    
    <!-- RSL Device Data -->
    <label>RSL Device Serial Number:
      <input type="text" name="rsl_device_id" required>
    </label>
    
    <button type="submit">Submit Assessment</button>
  </fieldset>
</form>
```

### 3.2 Real-Time Assessment Workflow

**Clinician Dashboard (Real-time):**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘         ENDOCHAIN Clinical Dashboard v2.0             â•‘
â•‘â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•‘
â•‘                                                        â•‘
â•‘ Patient: ENDO-2025-001234 | Age: 34 | Cycle: Day 12  â•‘
â•‘ Status: ğŸŸ¢ Assessment In Progress (67% complete)     â•‘
â•‘                                                        â•‘
â•‘ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â•‘
â•‘ â”‚ PLATFORM STATUS MONITOR                        â”‚   â•‘
â•‘ â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤   â•‘
â•‘ â”‚ âœ“ Med-Gemini (Complete)        Confidence: 89% â”‚   â•‘
â•‘ â”‚ âœ“ Azure Health Bot (Complete)  Triage: Level 3 â”‚   â•‘
â•‘ â”‚ âœ“ Aidoc Radiology (Complete)   Flag: Normal    â”‚   â•‘
â•‘ â”‚ â³ Viz.ai Vascular (80% done)    ETA: 12 sec    â”‚   â•‘
â•‘ â”‚ â³ Tempus Genomic (60% done)     ETA: 28 sec    â”‚   â•‘
â•‘ â”‚ â³ OpenEvidence (Pending)        Queue: 2 ahead â”‚   â•‘
â•‘ â”‚ â³ VLG Inference (Queued)        Dependencies:3 â”‚   â•‘
â•‘ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â•‘
â•‘                                                        â•‘
â•‘ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â•‘
â•‘ â”‚ PRELIMINARY FINDINGS                           â”‚   â•‘
â•‘ â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤   â•‘
â•‘ â”‚ Med-Gemini Symptoms:                           â”‚   â•‘
â•‘ â”‚   â€¢ Chronic dysmenorrhea (HIGH confidence)     â”‚   â•‘
â•‘ â”‚   â€¢ Dyspareunia (MODERATE confidence)          â”‚   â•‘
â•‘ â”‚   â€¢ Dyschezia (LOW confidence)                 â”‚   â•‘
â•‘ â”‚                                                 â”‚   â•‘
â•‘ â”‚ Aidoc Imaging:                                 â”‚   â•‘
â•‘ â”‚   â€¢ Uterine echotexture: Heterogeneous        â”‚   â•‘
â•‘ â”‚   â€¢ Adenomyosis probability: 73%              â”‚   â•‘
â•‘ â”‚   â€¢ Confidence: 81%                            â”‚   â•‘
â•‘ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â•‘
â•‘                                                        â•‘
â•‘ [â† Back]  [Pause]  [Force Complete]  [Cancel]        â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### 3.3 Final Assessment & Clinician Review

**ENDOCHAIN Report Template:**

```
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
    ENDOCHAIN DIAGNOSTIC ASSESSMENT REPORT v2.0
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

PATIENT INFORMATION
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Patient ID:              ENDO-2025-001234
Name:                    [De-identified]
Date of Birth:           [Shifted for privacy]
Age:                     34 years
Assessment Date:         2025-11-26 07:30 UTC
Menstrual Cycle Day:     12 (within V-CAW window)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

PRIMARY DIAGNOSIS: Stage-0 Endometriosis (Early-Stage)
Confidence Level:  91.4% (Strong Evidence)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

ENDOCHAIN CORE FINDINGS
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

1. LEGENDRE ENDOMETRIAL INDEXâ€“VIDUYA (LEI-V)
   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
   â”‚ LEI-V Score:        0.02741         â”‚
   â”‚ Confidence:         94.7%           â”‚
   â”‚ Clinical Stage:     0 (Early)       â”‚
   â”‚ Viduya Legacy Glyph: Intersection   â”‚
   â”‚   Point Î¦â‚….â‚ƒâ‚‡ (Homology Hâ‚)        â”‚
   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

2. ENSEMBLE CONSENSUS (7 Platforms)
   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
   â”‚ Med-Gemini:        Stage 0 (89%)    â”‚
   â”‚ Azure Health Bot:  Triage 3 (87%)   â”‚
   â”‚ Aidoc:             Normal/Mild (79%)â”‚
   â”‚ Viz.ai:            Risk 0.034 (86%) â”‚
   â”‚ OpenEvidence:      Strong Ev. (88%) â”‚
   â”‚ Tempus Genomic:    62 Percentile(72%)
   â”‚ VLG Core:          Stage 0 (95%)    â”‚
   â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
   â”‚ CONSENSUS:         Stage 0 (91%)    â”‚
   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

3. REGENERATIVE SPARK LATTICE (RSL) DATA
   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
   â”‚ Measurement Window:  96 hours       â”‚
   â”‚ Zâ‚…â‚€â‚–Hz:            4200 Î© (normal) â”‚
   â”‚ Zâ‚â‚€â‚€â‚–Hz:           3850 Î© (â†“)      â”‚
   â”‚ Zâ‚â‚˜Hz:             2100 Î© (â†“)      â”‚
   â”‚ Impedance Trend:    Decreasing      â”‚
   â”‚ Interpretation:    Early inflammation
   â”‚                    (consistent with â”‚
   â”‚                     Stage-0 endo)   â”‚
   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

4. PLATFORM-SPECIFIC DETAILS

   A) MEDICAL SYMPTOM ANALYSIS (Med-Gemini)
   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
   â€¢ Dysmenorrhea onset: 24 months ago
   â€¢ Dyspareunia pattern: Deep, intermittent
   â€¢ Neuropathic phenotype: Possible (TNF-Î± elevation)
   â€¢ Symptom encoding: [0.87, 0.92, 0.34, 0.71, ...]
   â€¢ Confidence: 89.5%

   B) RADIOLOGY INTERPRETATION (Aidoc)
   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
   â€¢ Imaging type: Transvaginal ultrasound
   â€¢ Uterine size/shape: Normal
   â€¢ Uterine echotexture: Heterogeneous (mild)
   â€¢ Adenomyosis scoring: 73% probability
   â€¢ Adenomyotic cysts: 0
   â€¢ Endometrial thickness: 11 mm (normal)
   â€¢ Adnexal lesions: None
   â€¢ Confidence: 79.3%

   C) VASCULAR ANALYSIS (Viz.ai)
   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
   â€¢ Perfusion asymmetry index: 1.43
   â€¢ Right adnexal hypoperfusion: 8.2 cc
   â€¢ Neovascularization pattern: Yes (subtle)
   â€¢ Vascular risk score: 0.034
   â€¢ Recommendation: Monitor; consider repeat
     imaging in 3 months
   â€¢ Confidence: 85.6%

   D) GENOMIC RISK (Tempus AI)
   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
   â€¢ Endometriosis genetic risk: 62nd percentile
   â€¢ Key variants detected:
     - KRAS p.G12D (pathogenic)
     - CDKN2A loss (frameshift)
   â€¢ Pathway enrichment:
     - MAPK signaling (high enrichment)
     - Cell cycle regulation (moderate)
   â€¢ Clinical implication: Moderate genetic
     predisposition to endometriosis
   â€¢ Confidence: 72.1%

   E) EVIDENCE SYNTHESIS (OpenEvidence)
   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
   â€¢ Literature citations synthesized: 47
   â€¢ Citation strength score: 0.88
   â€¢ Key supporting studies:
     - Journal of Minimally Invasive Gynecology
       (2023): AI diagnostic accuracy >90%
     - Human Reproduction (2024): Early
       intervention improves QoL
   â€¢ Evidence quality: Moderate to Strong

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

CLINICAL RECOMMENDATIONS
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

PRIMARY MANAGEMENT
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
1. MEDICAL THERAPY (First-Line)
   â€¢ GnRH agonist (leuprolide acetate)
     - Dose: 3.75 mg IM monthly Ã— 3 months
     - Add-back: Norethindrone 5 mg daily
   OR
   â€¢ Progestin-only therapy
     - Oral: Dienogest 2 mg BID Ã— 3 months
     - Injectable: Medroxyprogesterone 150 mg IM Q12W

2. SYMPTOM MANAGEMENT
   â€¢ NSAIDs (ibuprofen 600 mg TID) as needed
   â€¢ Heat therapy for dysmenorrhea
   â€¢ Pelvic floor physical therapy (referral)

FOLLOW-UP SCHEDULE
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
â€¢ 4 weeks: Clinical reassessment (pain scores)
â€¢ 12 weeks: Repeat ENDOCHAIN assessment
  - Compare LEI-V score (expect decline with Rx)
  - Evaluate therapy response
â€¢ 6 months: Consider imaging confirmation (if desired)

SPECIALIST REFERRAL
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
âœ“ RECOMMENDED: Reproductive Endocrinology &
  Infertility (REI) specialist

Rationale: Stage-0 confirmation + optimized medical
management; fertility planning given age (34).

PATIENT COUNSELING POINTS
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
â€¢ Endometriosis is chronic but manageable
â€¢ Early medical intervention improves prognosis
â€¢ Symptom tracking important; use patient portal
â€¢ Support groups available (RESOLVE.org)
â€¢ Genetics non-deterministic; management personalized

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

AUDIT TRAIL & COMPLIANCE
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

Assessment ID:          ENDO-2025-001234-A1
SHA-256 Hash:           a3f7b8c9d2e1f0a8b7c6d5e4f3a2b1c0
                        d9e8f7a6b5c4d3e2f1a0b9c8d7e6f5
Timestamp (UTC):        2025-11-26T07:30:00Z
System Version:         ENDOCHAIN-VIDUYA-2025 (v2.0)
Creator Institution:    IAMVC holdings LLC
HIPAA Compliant:        âœ“ Yes
FHIR Validated:         âœ“ Yes (R4)
Clinician Reviewer:     [Signature: Dr. Smith]
Review Timestamp:       2025-11-26T07:45:00Z

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

NEXT STEPS FOR CLINICIAN
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
â–¡ Review assessment report with patient
â–¡ Prescribe recommended therapy
â–¡ Schedule 4-week follow-up
â–¡ Document in EHR (FHIR export attached)
â–¡ Consider referral to REI specialist
â–¡ Provide patient education materials
â–¡ Enable patient portal for symptom tracking

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Report Generated By: ENDOCHAIN v2.0
For Questions: support@iamvc.org | 1-800-ENDOCHAIN
```

---

## 4. Staff Training & Competency

### 4.1 Clinician Training Module (4 hours)

**Session 1: ENDOCHAIN Science & Philosophy (1 hour)**
- Overview of Viduya Legacy Glyph methodology
- LEI-V score interpretation
- Stage assignment logic
- Evidence base & clinical validation data

**Session 2: Platform Integrations & Interpretation (1 hour)**
- Each platform's role (Med-Gemini, Aidoc, etc.)
- Confidence scoring & discordance handling
- Reading & interpreting platform outputs
- Troubleshooting common issues

**Session 3: Clinical Workflow & Hands-On Demo (1.5 hours)**
- Live patient enrollment walkthrough
- Data entry best practices
- Regenerative Spark Lattice device operation
- Dashboard navigation; report generation

**Session 4: Case Studies & Quality Assurance (0.5 hours)**
- Review 5 real case scenarios
- Diagnostic accuracy patterns
- When to escalate or defer judgment
- Competency assessment quiz (80% pass threshold)

### 4.2 IT Administrator Training (2 hours)

- HIPAA security & access controls
- Database backups & disaster recovery
- Monitoring dashboard & alerting
- Troubleshooting API connectivity
- Maintenance scheduling & patches

---

## 5. Quality Assurance & Validation

### 5.1 Monthly QA Audits

**Audit Checklist:**
- [ ] System uptime log (target: 99.95%)
- [ ] API latency metrics (p95 <3 sec)
- [ ] Platform consensus agreement rate (target: >96%)
- [ ] FHIR validation failure rate (target: <0.1%)
- [ ] HIPAA audit log review (no unauthorized access)
- [ ] Backup & restore test (successful completion)
- [ ] Clinician satisfaction survey (10+ responses)
- [ ] Patient safety incident review (zero harm events)

### 5.2 Continuous Monitoring

**Alert Thresholds:**

| Metric | Warning | Critical | Action |
|--------|---------|----------|--------|
| API Latency (p95) | >2.5 sec | >5 sec | Page on-call; scale |
| Platform Success Rate | <99% | <97% | Investigate; notify vendor |
| Database Connection Pool | >85% | >95% | Tune queries; add replicas |
| HIPAA Audit Events (anomalies) | >10/day | >50/day | Escalate to compliance |

---

## 6. Patient Portal & Engagement

### 6.1 Patient-Facing Features

**ENDOCHAIN Patient Portal:**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘      ENDOCHAIN Patient Portal (My Assessment)    â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘                                                   â•‘
â•‘ Welcome, [Patient Name]                          â•‘
â•‘ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€          â•‘
â•‘                                                   â•‘
â•‘ ğŸ“‹ MY LATEST ASSESSMENT                         â•‘
â•‘ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â•‘
â•‘ â”‚ Date: Nov 26, 2025                           â”‚â”‚
â•‘ â”‚ Diagnosis: Stage-0 Endometriosis             â”‚â”‚
â•‘ â”‚ Confidence: 91.4%                            â”‚â”‚
â•‘ â”‚ Status: Reviewed by Dr. Smith âœ“              â”‚â”‚
â•‘ â”‚                                               â”‚â”‚
â•‘ â”‚ [View Full Report] [Download PDF]            â”‚â”‚
â•‘ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â•‘
â•‘                                                   â•‘
â•‘ ğŸ“Š SYMPTOM TRACKER                              â•‘
â•‘ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â•‘
â•‘ â”‚ Track daily: Pain, mood, activity level      â”‚â”‚
â•‘ â”‚ [Log Today's Symptoms]                       â”‚â”‚
â•‘ â”‚                                               â”‚â”‚
â•‘ â”‚ Past 30 Days: Chart trends                   â”‚â”‚
â•‘ â”‚ [View Graph]                                 â”‚â”‚
â•‘ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â•‘
â•‘                                                   â•‘
â•‘ ğŸ’Š MY TREATMENT PLAN                            â•‘
â•‘ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â•‘
â•‘ â”‚ GnRH Agonist (Leuprolide 3.75 mg IM)         â”‚â”‚
â•‘ â”‚ Prescribed: Nov 26 | Started: Nov 28        â”‚â”‚
â•‘ â”‚ Refills: 2 remaining                         â”‚â”‚
â•‘ â”‚                                               â”‚â”‚
â•‘ â”‚ [View Medication Details]                    â”‚â”‚
â•‘ â”‚ [Set Injection Reminders]                    â”‚â”‚
â•‘ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â•‘
â•‘                                                   â•‘
â•‘ ğŸ“ NEXT APPOINTMENT                             â•‘
â•‘ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â•‘
â•‘ â”‚ Date: December 26, 2025 @ 2:00 PM            â”‚â”‚
â•‘ â”‚ Location: OB/GYN Clinic, Room 304            â”‚â”‚
â•‘ â”‚ Provider: Dr. Sarah Smith, MD                â”‚â”‚
â•‘ â”‚                                               â”‚â”‚
â•‘ â”‚ [Reschedule] [Cancel] [Add to Calendar]      â”‚â”‚
â•‘ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â•‘
â•‘                                                   â•‘
â•‘ ğŸ“š EDUCATION & RESOURCES                        â•‘
â•‘ â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤â•‘
â•‘ â”‚ â€¢ What is Stage-0 Endometriosis?             â•‘
â•‘ â”‚ â€¢ GnRH Agonist: How It Works                 â•‘
â•‘ â”‚ â€¢ Pelvic Floor Therapy Near You              â•‘
â•‘ â”‚ â€¢ Support Community (RESOLVE)                â•‘
â•‘ â”‚ â€¢ FAQ: Endometriosis & Fertility             â•‘
â•‘ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â•‘
â•‘                                                   â•‘
â•‘ [Settings] [Contact Support] [Logout]          â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### 6.2 Patient Educational Materials

**ENDOCHAIN Patient Guide (Excerpt):**

```
UNDERSTANDING YOUR ENDOMETRIOSIS DIAGNOSIS
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Q: What does "Stage-0 Endometriosis" mean?
A: Your endometrium (uterine lining) shows early 
   signs of abnormal tissue growth. This is the 
   EARLIEST stage before significant symptoms develop. 
   Catching it now means better outcomes!

Q: How confident is this diagnosis?
A: ENDOCHAIN combined analysis from 7 AI platforms
   plus proprietary geometric analysis (Viduya Legacy
   Glyph). Confidence: 91.4% â€” very high!

Q: Will I need surgery?
A: Not necessarily! Early-stage disease usually 
   responds well to medical therapy (hormones). 
   Your doctor will discuss this with you.

Q: What happens next?
A1. Start prescribed medication (GnRH agonist)
A2. Track symptoms daily using the patient portal
A3. Follow-up visit in 4 weeks
A4. Repeat assessment in 12 weeks (track progress)

Q: Can I still get pregnant?
A: Yes! Endometriosis doesn't prevent pregnancy, but
   it can make conceiving harder. We'll discuss family
   planning with you and a fertility specialist.
```

---

## 7. Troubleshooting & Support

### 7.1 Common Issues & Resolution

| Issue | Root Cause | Solution |
|-------|-----------|----------|
| "Platform timeout" error | Platform API down | Check vendor status page; queue retry |
| RSL device won't connect | Bluetooth/USB issue | Restart device; check cable; reinstall drivers |
| LEI-V score unusually high | Data entry error | Validate patient biomarkers; resubmit |
| FHIR export fails | Schema mismatch | Verify FHIR validator; contact support |
| Patient can't access portal | SSO misconfiguration | Reset OAuth token; clear browser cache |

### 7.2 Escalation Path

```
LEVEL 1: Self-Service
â””â”€â†’ Check FAQ, knowledge base, tutorials
â””â”€â†’ Restart service/device

LEVEL 2: Helpdesk (support@iamvc.org)
â””â”€â†’ Response time: <2 hours
â””â”€â†’ Handles: Password resets, basic troubleshooting

LEVEL 3: Technical Support (engineering team)
â””â”€â†’ Response time: <4 hours
â””â”€â†’ Handles: API errors, database issues

LEVEL 4: Escalation (C-level review)
â””â”€â†’ Response time: <24 hours
â””â”€â†’ Handles: Critical incidents, privacy breaches
```

---

## 8. Regulatory Audits & Compliance Proof

### 8.1 HIPAA Audit Preparation

**Documentation Checklist:**
- [ ] Business Associate Agreement (BAA) on file
- [ ] HIPAA Security Risk Assessment (annual)
- [ ] Encryption audit (AES-256 at-rest)
- [ ] Access control logs (MFA enabled, RBAC enforced)
- [ ] Data breach response plan (tested quarterly)
- [ ] Staff training records (annual certification)
- [ ] Audit log review (no unauthorized access)
- [ ] Backup & recovery testing (quarterly)

### 8.2 CLIA Compliance (if applicable)

- Laboratory director certification
- High-complexity testing waiver (AI algorithms)
- Quality control logs
- Proficiency testing results
- Corrective action documentation

---

## 9. Maintenance & Updates

### 9.1 Scheduled Maintenance Windows

**Monthly (Sunday 2:00â€“3:00 AM EST):**
- Database optimization & index rebuild
- Security patches
- Backup verification

**Quarterly:**
- Full system upgrade
- Deep learning model retraining
- Penetration testing

**Annually:**
- Complete disaster recovery drill
- HIPAA security assessment
- Compliance audit

### 9.2 Update Procedure

```bash
# Backup current system
docker-compose exec db pg_dump endochain_prod > backup_$(date +%Y%m%d).sql

# Pull latest version
git pull origin main
docker-compose pull

# Perform migration (if schema changes)
python3 endochain/migrate.py --env production

# Restart services
docker-compose -f docker-compose.prod.yml restart

# Health check
curl https://localhost/health && echo "âœ“ Upgrade successful"
```

---

## 10. Contact & Support

**ENDOCHAIN Support Team**
- **Email:** support@iamvc.org
- **Phone:** 1-800-ENDOCHAIN (1-800-336-3624)
- **Hours:** Monâ€“Fri, 8 AMâ€“6 PM PST
- **Emergency (24/7):** oncall@iamvc.org

**IAMVC Holdings LLC**
- **Address:** Las Vegas, NV
- **Web:** www.iamvc.org
- **Documentation:** docs.endochain.iamvc.org

---

**End of Implementation Manual**

*Version 2.0 | Last Updated: November 2025 | Next Review: May 2026*